US pharmaceutical giant Pfizer could make a hostile bid for AstraZeneca as early as today.
Its £63 billion takeover offer was rejected after the UK company said it "substantially" undervalued the business.
That has forced Pfizer to consider its next move, with industry experts believing a hostile bid - which would aim to bypass the AstraZeneca management and target shareholders directly - could come soon.
Last week, Pfizer insisted it was committed to building a research and development hub in Cambridge which was planned by AstraZeneca.
The £300m base at the Cambridge Biomedial Campus would house about 2,000 researchers.
But a hostile bid would trigger increased calls for the offer to be referred to the competition authorities and would also heighten union fears over jobs if the takeover was successful.
More top news
Norwich City's faint hopes of making the play-offs in The Championship took a big blow after they lost 2-1 at home to Sheffield United.
Clear periods in the northwest will allow icy patches to develop. However elsewhere, low cloud, patchy mist and fog are likely.
Suffolk singer Ed Sheeran has announced his engagement to girlfriend Cherry Seaborn.